A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma	Advanced Melanoma	Active, not recruiting	Phase 2	2026-01-16		NCT05529316

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Agenus Inc.	23

51 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HP Hopital Saint-Louis	Paris	France	4
Azienda Ospedaliero Universitaria Senese	Siena	Italy	4
Blokhin National Medical Research Oncology Centre	Moscow	Russia	1
Branch Office of "Hadassah Medical Ltd"	Moscow	Russia	1
Centre Eugene Marquis	Rennes	France	26
Centre Leon Berard	Lyon	France	70
Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho	Jaú	Brazil	1
Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa	Porto Alegre	Brazil	4
Chu Amiens Picardie - Hopital Sud	Amiens	France	3
Chu de Nantes	Nantes	France	72
CHU Grenoble-Alpes - Hopital Michallon	La Tronche	France	2
CHUV - Centre Hospitalier Universitaire Vaudois	Lausanne	Switzerland	2
Clinical Hospital Russian Railways - Medicine	Saint Petersburg	Russia	1
Consorcio Hospital General Universitario de Valencia	Valencia	Spain	7
Dana-Farber Cancer Institute	Boston	United States	626
Georgetown University Medical Center	Washington D.C.	United States	11
Gustave Roussy	Villejuif	France	47
Hospital A.C. Camargo Cancer Center	São Paulo	Brazil	2
Hospital Clinic Barcelona	Barcelona	Spain	2
Hospital General Universitario Gregorio Maranon	Madrid	Spain	44
Hospital Sirio Libanes	São Paulo	Brazil	8
Hospital Universitario 12 de Octubre	Madrid	Spain	359
Hospital Universitario Vall d'Hebron	Barcelona	Spain	5
Hospital Universitario Virgen Macarena	Seville	Spain	116
INCA II - Instituto Nacional de Cancer Jose Alencar Gomes da Silva	Rio de Janeiro	Brazil	1

Clinical trials